Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.
2.

The combined use of cholesterol-lowering drugs and cholesterol-lowering bread spreads: health behavior data from Finland.

de Jong N, Simojoki M, Laatikainen T, Tapanainen H, Valsta L, Lahti-Koski M, Uutela A, Vartiainen E.

Prev Med. 2004 Nov;39(5):849-55.

PMID:
15475015
3.

Consistency of use of plant stanol ester margarine in Finland.

Luoto R, Simojoki M, Uutela A, Boice JD Jr, McLaughlin JK, Puska P.

Public Health Nutr. 2004 Feb;7(1):63-8.

PMID:
14972073
4.
5.

Carboxyterminal telopeptide of type I collagen (ICTP) in predicting prognosis in epithelial ovarian cancer.

Simojoki M, Santala M, Risteli J, Kauppila A.

Gynecol Oncol. 2001 Jul;82(1):110-5.

PMID:
11426971
6.

Serial determinations of aminoterminal propeptide of type III procollagen (PIIINP) and prognosis in ovarian cancer; comparison to CA125.

Simojoki M, Santala M, Risteli J, Risteli L, Kauppila A.

Anticancer Res. 2000 Nov-Dec;20(6C):4655-60.

PMID:
11205196
7.

Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.

Santala M, Simojoki M, Risteli J, Risteli L, Kauppila A.

Clin Cancer Res. 1999 Dec;5(12):4091-6.

8.

The prognostic value of peritoneal cytology in ovarian cancer.

Simojoki M, Santala M, Vuopala S, Kauppila A.

Eur J Gynaecol Oncol. 1999;20(5-6):357-60.

PMID:
10609494
9.

Ultrasound-controlled removal of a dislocated intrauterine device in the first trimester of pregnancy: a report of 26 cases.

Kirkinen P, Simojoki M, Kivelä A, Jouppila P.

Ultrasound Obstet Gynecol. 1992 Sep 1;2(5):345-8.

Supplemental Content

Loading ...
Support Center